Dr. Andrea Fran Katz, MD

Dr. Katz practices at New York Eye and Ear Infirmary of Mount Sinai in New York, New York, part of Mount Sinai Health System.

Dr. Katz's NPI, 1154437895, was assigned on August 23, 2006. Dr. Katz graduated from Johns Hopkins University School of Medicine in 1982. Dr. Katz holds New York license 152039.

Dr. Katz's primary practice is New York Eye and Ear Infirmary of Mount Sinai, at 230 Second Ave, New York, NY 10003 in New York County. The practice phone is (212) 979-4000. Dr. Katz also practices at New York Eye & Ear Infirmary, 310 E 14th St, New York, NY 10003.

Dr. Katz's primary practice is New York Eye and Ear Infirmary of Mount Sinai in New York, New York, part of Mount Sinai Health System. Dmand AI also links Dr. Katz to 1 physician office, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Katz practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Katz's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Katz is licensed in New York.

CMS data shows 2,514 Medicare services from Dr. Katz across 12 procedure codes in 2024, for 345 Medicare patients. Medicare paid $118,089 for them.

CMS counts 345 Medicare patients who saw Dr. Katz in 2024. The largest group is 75 to 84, with 151 patients. 75% of them have high cholesterol, and 65% have high blood pressure. 5% are also on Medicaid. Their average risk score is 0.97, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Katz's median patient age at 65, with 64% women.

In 2024, Dr. Katz wrote 2,691 Medicare Part D claims for 296 patients. 60% of them were for generic drugs. CMS names the drug for 2,595 of them, across 28 drugs with 11 or more claims each, at $416,696 in total drug cost. In 2023, CMS named 2,604 claims across 27 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 25 out of 100 for Dr. Katz for performance year 2024, reported individually. Dr. Katz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 65 procedures of cataract surgery by Dr. Katz, more than 68% of the clinicians it reports for that procedure.

CMS Open Payments shows 27 general payments to Dr. Katz from 12 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Aerie Pharmaceuticals, Inc. paid the most, $437.

Dr. Katz graduated from Johns Hopkins University School of Medicine in 1982.